New Delhi [India], January 5 (ANI/NewsVoir): BSE and NSE listed Vikas Multicorp Ltd., in their release to the exchanges, announced its agenda of the board meeting scheduled to be held on 12 January, 2021 in which, other than the 3rd quarter results that would be approved, the board is schedu
Chandigarh (Punjab) [India], January 4 (ANI): As many as 8,830 healthcare workers including private healthcare providers have been registered in Chandigarh, which are to be administered vaccination in the first phase, informed Punjab Governor and Chandigarh Administrator VP Singh Badnore on
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
New Delhi [India], January 3 (ANI): As the country is eagerly waiting for the COVID-19 vaccination programme to begin, Dr Manoj Kumar, senior cardiologist at Max Hospital, New Delhi said that in the first phase, almost 30 crore population will be covered.
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
New Delhi [India], January 2 (ANI/NewsVoir): In this new year, Alniche Lifesciences has achieved a new milestone by venturing into manufacturing in its state-of-the-art facility under the name of EffiKasia Lifesciences at Kangra, Himachal Pradesh.
London [UK], January 2 (ANI): England Test skipper Joe Root feels rotation of players will be an integral part of cricket's new phase amid the coronavirus scare.
Kathmandu [Nepal], January 2 (ANI): Amid political chaos, the Prachanda faction will announce the second phase of demonstrations in the capital city on Saturday.
Mumbai (Maharashtra) [India], December 30 (ANI): Equity benchmark indices were flat during early hours on Wednesday as traders booked profits on banking and financial counters.
Mumbai (Maharashtra) [India], Dec 24 (ANI): Equity benchmark indices closed over 1 per cent higher on Thursday as investors put their bets on global economic recovery prospects.
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.